• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁香酚通过抑制 ALDH 阳性乳腺癌干细胞和 NF-κB 信号通路增强顺铂的抗癌活性。

Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.

机构信息

Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Department of Infection and Immunity, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

出版信息

Mol Carcinog. 2018 Mar;57(3):333-346. doi: 10.1002/mc.22758. Epub 2017 Nov 24.

DOI:10.1002/mc.22758
PMID:29073729
Abstract

Triple-negative breast tumors are very aggressive and contain relatively high proportion of cancer stem cells, and are resistant to chemotherapeutic drugs including cisplatin. To overcome these limitations, we combined eugenol, a natural polyphenolic molecule, with cisplatin to normalize cisplatin mediated toxicity and potential drug resistance. Interestingly, the combination treatment provided significantly greater cytotoxic and pro-apoptotic effects as compared to treatment with eugenol or cisplatin alone on several triple-negative breast cancer cells both in vitro and in vivo. Furthermore, adding eugenol to cisplatin potentiated the inhibition of breast cancer stem cells by inhibiting ALDH enzyme activity and ALDH-positive tumor initiating cells. We provide also clear evidence that eugenol potentiates cisplatin inhibition of the NF-κB signaling pathway. Indeed, the binding of NF-κB to its cognate binding sites present in the promoters of IL-6 and IL-8 was dramatically reduced, which led to potent down-regulation of the IL-6 and IL-8 cytokines upon combination treatment relative to the single agents. Similar effects were observed on proliferation, inhibition of epithelial-to-mesenchymal transition and stemness markers in tumor xenografts. These results provide strong preclinical justification for combining cisplatin with eugenol as therapeutic approach for triple-negative breast cancers through targeting the resistant ALDH-positive cells and inhibiting the NF-κB pathway.

摘要

三阴性乳腺癌肿瘤非常具有侵袭性,并且含有相对较高比例的癌症干细胞,对包括顺铂在内的化疗药物具有耐药性。为了克服这些局限性,我们将天然多酚分子丁香酚与顺铂联合使用,使顺铂介导的毒性和潜在耐药性正常化。有趣的是,与单独使用丁香酚或顺铂相比,联合治疗在体外和体内对几种三阴性乳腺癌细胞均表现出显著更大的细胞毒性和促凋亡作用。此外,丁香酚与顺铂联合使用通过抑制 ALDH 酶活性和 ALDH 阳性肿瘤起始细胞来增强对乳腺癌干细胞的抑制作用。我们还提供了明确的证据表明,丁香酚增强了顺铂对 NF-κB 信号通路的抑制作用。事实上,NF-κB 与其在 IL-6 和 IL-8 启动子中存在的同源结合位点的结合显著减少,这导致与单一药物相比,联合治疗时 IL-6 和 IL-8 细胞因子的表达水平显著下调。在肿瘤异种移植物中的增殖、上皮-间充质转化和干细胞标志物的抑制方面也观察到了类似的效果。这些结果为通过靶向耐药性 ALDH 阳性细胞和抑制 NF-κB 通路,将顺铂与丁香酚联合作为治疗三阴性乳腺癌的方法提供了强有力的临床前依据。

相似文献

1
Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.丁香酚通过抑制 ALDH 阳性乳腺癌干细胞和 NF-κB 信号通路增强顺铂的抗癌活性。
Mol Carcinog. 2018 Mar;57(3):333-346. doi: 10.1002/mc.22758. Epub 2017 Nov 24.
2
Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.托珠单抗增强顺铂细胞毒性并靶向三阴性乳腺癌中的肿瘤干细胞。
Mol Carcinog. 2020 Sep;59(9):1041-1051. doi: 10.1002/mc.23234. Epub 2020 Jun 14.
3
Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway.顺铂联合丁香酚通过 Notch-Hes1 信号通路靶向卵巢癌干细胞。
J Exp Clin Cancer Res. 2019 Aug 30;38(1):382. doi: 10.1186/s13046-019-1360-3.
4
Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.双硫仑调节活性氧积累并协同克服乳腺癌细胞系的顺铂耐药性。
Biomed Pharmacother. 2019 May;113:108727. doi: 10.1016/j.biopha.2019.108727. Epub 2019 Mar 12.
5
Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.硝唑尼特与顺铂联合使用可抑制顺铂耐药三阴性乳腺癌中的上皮-间质转化和肿瘤生长。
Tumour Biol. 2016 Jul;37(7):9825-35. doi: 10.1007/s13277-015-4650-1. Epub 2016 Jan 26.
6
Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.热休克蛋白 27 通过调节上皮-间充质转化和核因子-κB 参与乳腺癌干细胞的维持。
Breast Cancer Res. 2011 Oct 24;13(5):R101. doi: 10.1186/bcr3042.
7
The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.靶向治疗 FGFR1/Src/NF-κB 信号轴抑制胰腺导管腺癌干性和致瘤性。
Clin Exp Metastasis. 2018 Oct;35(7):663-677. doi: 10.1007/s10585-018-9919-5. Epub 2018 Jul 9.
8
Eugenol modulates the NOD1-NF-κB signaling pathway targeting NF-κB protein in triple-negative breast cancer cells.丁香酚通过靶向三阴性乳腺癌细胞中的 NF-κB 蛋白调节 NOD1-NF-κB 信号通路。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1136067. doi: 10.3389/fendo.2023.1136067. eCollection 2023.
9
Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness.人参皂苷 Rg3 通过阻断 NF-κB 介导的上皮-间充质转化和干性来增强缺氧肺癌细胞对顺铂的敏感性。
Cancer Lett. 2018 Feb 28;415:73-85. doi: 10.1016/j.canlet.2017.11.037. Epub 2017 Dec 2.
10
Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.三阴性乳腺癌肿瘤起始细胞中改变的信号通路解析:一种用于药物筛选的有用细胞模型系统
Stem Cells. 2017 Aug;35(8):1898-1912. doi: 10.1002/stem.2654. Epub 2017 Jun 23.

引用本文的文献

1
Plant metabolites and functional foods in metastatic breast cancer: a supportive strategy for management.植物代谢产物与功能性食品在转移性乳腺癌中的作用:一种辅助治疗策略
Front Pharmacol. 2025 Jul 23;16:1631232. doi: 10.3389/fphar.2025.1631232. eCollection 2025.
2
Translational drugs targeting cancer stem cells in triple-negative breast cancer.靶向三阴性乳腺癌癌干细胞的转化药物
Mol Ther Oncol. 2025 Jun 13;33(3):201008. doi: 10.1016/j.omton.2025.201008. eCollection 2025 Sep 18.
3
Eugenol alleviates renal ischemia-reperfusion injury induced-endoplasmic reticulum stress via activating Sestrin2.
丁香酚通过激活Sestrin2减轻内质网应激诱导的肾缺血再灌注损伤。
Clinics (Sao Paulo). 2025 Mar 25;80:100627. doi: 10.1016/j.clinsp.2025.100627. eCollection 2025.
4
IL-8-NF-κB-ALDH1A1 loop promotes the progression of intrahepatic cholangiocarcinoma.白细胞介素-8-核因子-κB-醛脱氢酶1A1环路促进肝内胆管癌进展。
Hepatol Commun. 2025 Feb 26;9(3). doi: 10.1097/HC9.0000000000000664. eCollection 2025 Mar 1.
5
Eugenol Promotes Apoptosis in Leukemia Cells via Targeting the Mitochondrial Biogenesis PPRC1 Gene.丁香酚通过靶向线粒体生物发生相关基因PPRC1促进白血病细胞凋亡。
Cells. 2025 Feb 12;14(4):260. doi: 10.3390/cells14040260.
6
A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors.一项对临床前研究中六种作为潜在乳腺癌抑制剂的生物活性化合物的综述。
Mol Biol Rep. 2025 Feb 5;52(1):203. doi: 10.1007/s11033-025-10300-0.
7
Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.实体瘤癌症干细胞中膳食化合物的分子机制:对结直肠癌、乳腺癌和前列腺癌的见解
Int J Mol Sci. 2025 Jan 13;26(2):631. doi: 10.3390/ijms26020631.
8
Plant-Based Anticancer Compounds With a Focus on Breast Cancer.植物源抗癌化合物及其在乳腺癌中的作用
Cancer Rep (Hoboken). 2024 Oct;7(10):e70012. doi: 10.1002/cnr2.70012.
9
Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review.新型抗癌干细胞化合物:全面综述
Pharmaceutics. 2024 Aug 1;16(8):1024. doi: 10.3390/pharmaceutics16081024.
10
Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016-2023).苯并咪唑支架作为一种具有不同作用机制的有效抗癌剂(2016 - 2023年)
Mol Divers. 2025 Apr;29(2):1821-1849. doi: 10.1007/s11030-024-10907-8. Epub 2024 Jul 20.